138 related articles for article (PubMed ID: 25808872)
1. Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell Activation.
Jachetti E; Caputo S; Mazzoleni S; Brambillasca CS; Parigi SM; Grioni M; Piras IS; Restuccia U; Calcinotto A; Freschi M; Bachi A; Galli R; Bellone M
Cancer Res; 2015 May; 75(10):2095-108. PubMed ID: 25808872
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.
Caputo S; Grioni M; Brambillasca CS; Monno A; Brevi A; Freschi M; Piras IS; Elia AR; Pieri V; Baccega T; Lombardo A; Galli R; Briganti A; Doglioni C; Jachetti E; Bellone M
Front Immunol; 2020; 11():1820. PubMed ID: 33013832
[TBL] [Abstract][Full Text] [Related]
3. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
[TBL] [Abstract][Full Text] [Related]
4. The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance.
Di Carlo E; D'Antuono T; Pompa P; Giuliani R; Rosini S; Stuppia L; Musiani P; Sorrentino C
Clin Cancer Res; 2009 May; 15(9):2979-87. PubMed ID: 19366834
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix of glioblastoma inhibits polarization and transmigration of T cells: the role of tenascin-C in immune suppression.
Huang JY; Cheng YJ; Lin YP; Lin HC; Su CC; Juliano R; Yang BC
J Immunol; 2010 Aug; 185(3):1450-9. PubMed ID: 20622113
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.
Takahashi Y; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Anticancer Res; 2013 May; 33(5):1927-34. PubMed ID: 23645740
[TBL] [Abstract][Full Text] [Related]
7. RNAi-mediated silencing of Myc transcription inhibits stem-like cell maintenance and tumorigenicity in prostate cancer.
Civenni G; Malek A; Albino D; Garcia-Escudero R; Napoli S; Di Marco S; Pinton S; Sarti M; Carbone GM; Catapano CV
Cancer Res; 2013 Nov; 73(22):6816-27. PubMed ID: 24063893
[TBL] [Abstract][Full Text] [Related]
8. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
9. Altered immunity accompanies disease progression in a mouse model of prostate dysplasia.
Tien AH; Xu L; Helgason CD
Cancer Res; 2005 Apr; 65(7):2947-55. PubMed ID: 15805298
[TBL] [Abstract][Full Text] [Related]
10. The role of Tenascin C in the lymphoid progenitor cell niche.
Ellis SL; Heazlewood SY; Williams B; Reitsma AJ; Grassinger J; Borg J; Heazlewood CK; Chidgey AP; Nilsson SK
Exp Hematol; 2013 Dec; 41(12):1050-61. PubMed ID: 24084079
[TBL] [Abstract][Full Text] [Related]
11. Tenascin C regulates proliferation and differentiation processes during embryonic retinogenesis and modulates the de-differentiation capacity of Müller glia by influencing growth factor responsiveness and the extracellular matrix compartment.
Besser M; Jagatheaswaran M; Reinhard J; Schaffelke P; Faissner A
Dev Biol; 2012 Sep; 369(2):163-76. PubMed ID: 22691363
[TBL] [Abstract][Full Text] [Related]
12. Using self-assembled nanomaterials to inhibit the formation of metastatic cancer stem cell colonies in vitro.
Ling PM; Cheung SW; Tay DK; Ellis-Behnke RG
Cell Transplant; 2011; 20(1):127-31. PubMed ID: 20887677
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization.
Sorrentino C; Ciummo SL; Cipollone G; Caputo S; Bellone M; Di Carlo E
Cancer Res; 2018 May; 78(10):2654-2668. PubMed ID: 29487200
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen.
Aalamian M; Tourkova IL; Chatta GS; Lilja H; Huland E; Huland H; Shurin GV; Shurin MR
J Urol; 2003 Nov; 170(5):2026-30. PubMed ID: 14532846
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells, CD200 and immunoevasion.
Kawasaki BT; Farrar WL
Trends Immunol; 2008 Oct; 29(10):464-8. PubMed ID: 18775673
[TBL] [Abstract][Full Text] [Related]
16. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
[TBL] [Abstract][Full Text] [Related]
17. Age-related alterations in T-lymphocytes modulate key pathways in prostate tumorigenesis.
De Angulo A; Faris R; Cavazos D; Jolly C; Daniel B; DeGraffenried L
Prostate; 2013 Jun; 73(8):855-64. PubMed ID: 23532664
[TBL] [Abstract][Full Text] [Related]
18. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity.
Garcia-Hernandez Mde L; Gray A; Hubby B; Klinger OJ; Kast WM
Cancer Res; 2008 Feb; 68(3):861-9. PubMed ID: 18245488
[TBL] [Abstract][Full Text] [Related]
19. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
[TBL] [Abstract][Full Text] [Related]
20. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
